Lynx1 Capital Management LP

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 10,874,723 shares
Security Ownership %: 5.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Lynx1 Capital Management LP ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

14 Feb 2025 - Lynx1 Capital Management LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,874,723 shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 5.2% ownership of the company. This is the first filing by Lynx1 Capital Management LP disclosing ownership of Allogene Therapeutics, Inc. Common Stock (ALLO).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Lynx1 Capital Management LP	5.2%		$16,747,073	10,874,723			$1.54	13G	31 Dec 2024	14 Feb 2025, 09:02

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0.14%	$0	0	-546,119	-100%	$1.62	Q4 2025
30 Sep 2025	0.14%	-2.7%	$677,188	546,119	-10,510,890	-95%	$1.24	Q3 2025
30 Jun 2025	3.6%	0%	$12,494,420	11,057,009	0		$1.13	Q2 2025
31 Mar 2025	5.8%	+0.1%	$16,143,233	11,057,009	+182,286		$1.46	Q1 2025
31 Dec 2024	8.7%	+3.7%	$23,163,160	10,874,723	+4,672,349	+75%	$2.13	Q4 2024
30 Sep 2024	6.2%	+3.9%	$17,366,647	6,202,374	+3,974,079	+178%	$2.80	Q3 2024
30 Jun 2024	1.9%	+1.3%	$5,191,927	2,228,295	+2,228,295	NEW	$2.33	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.